Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase 2 Clinical Trial of Teclistamab and Daratumumab in Previously Untreated AL Amyloidosis
The purpose of this study is to investigate whether teclistamab-daratumumab combination is effective and safe in AL amyloidosis. The study treatment is divide…
Amyloid Light-chain Amyloidosis
Suzanne Lentzsch, MDNCT07110844
Phase 2
Dose Schedule Investigation of B-Cell Maturation Antigen (BCMA) Bispecific Antibody, Elranatamab, for Treatment of Newly Diagnosed Light Chain Amyloidosis
This research study is for people who have newly diagnosed with AL (light chain) amyloidosis and have not yet received any treatment for this condition. The pu…
Amyloid Light-chain Amyloidosis
Case Comprehensive Cancer CenterNCT07524634